CTRI/2024/03/064353Not yet recruitingPhase 4
Perilesional injections versus topical interferon alpha 2b in ocular surface squamous neoplasia - NI
Dr Rajendra Prasad Centre of Ophthalmic Sciences0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •All clinically and cytologically diagnosed OSSN
- •Patient willing to participate and follow up
Exclusion Criteria
- •Patient already on topical or perilesional immunotherapy/chemotherapy
- •/radiotherapy
- •Patient having any comorbidity
- •Intraocular or orbital OSSN (AJCC stage T3 OR T4)
Investigators
Similar Trials
Completed
Phase 3
Effect of administration of interferon alfa 2-b in treatment of pterygiumpterygium of eye.Pterygium of eyeH11.0IRCT20120817010617N5Zahedan University of Medical Sciences60
Completed
Phase 2
The efficacy of topical interferon alpha-2b in pterygiumpterygium.Pterygium of eyeH11.0IRCT20190806044463N1Bagheiat-allah University of Medical Sciences18
Recruiting
Phase 3
Trial of novel combined therapy between interferon and hyperlipidemia for chronic hepatitis C patientschronic hepatitis type CJPRN-UMIN000005598Kyoto University Graduate School of Medicine Center for Genomic Medicine100
Recruiting
Not Applicable
Efficacy and safety of interferon-free treatment in patients with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000037575Osaka university1,000
Not yet recruiting
Phase 4
Intravenous versus Subcutaneous Immunoglobuline therapy in Multifocal motor neuropathymotor neuropathynerve damage10034606NL-OMON31197Academisch Medisch Centrum10